Hepatic resection for metastatic tumors from gastric cancer
- PMID: 11753046
- PMCID: PMC1422399
- DOI: 10.1097/00000658-200201000-00011
Hepatic resection for metastatic tumors from gastric cancer
Abstract
Objective: To assess the surgical results and clinicopathologic features of hepatic metastases from gastric adenocarcinoma to identify patients with a better probability of survival.
Summary background data: Many studies have reported the benefit of hepatic resection for metastatic tumors from colorectal cancer. However, indications for a surgical approach for gastric adenocarcinoma involving the liver have not been clearly defined.
Methods: Ninety (11%) of 807 patients with primary gastric cancer were diagnosed with synchronous (n = 78) or metachronous (n = 12) hepatic metastases. Of these, 19 underwent 20 resections intended to cure the metastatic lesion in the liver. The clinicopathologic features of the hepatic metastases in, and the surgical results for, the 19 patients were analyzed.
Results: The actuarial 1-year, 3-year, and 5-year survival rates after hepatic resection were, respectively, 77%, 34%, and 34%, and three patients survived for more than 5 years after surgery. Solitary and metachronous metastases were significant determinants for a favorable prognosis after hepatic resection. Pathologically, a fibrous pseudocapsule between the tumor and surrounding hepatic parenchyma was found in 13 of the 19 patients (68%). The presence of a peritumoral fibrous pseudocapsule and a well-differentiated histologic type of metastatic nodule were significant prognostic factors. Factors associated with the primary lesion were not significant prognostic determinants in patients who underwent curative resection of the primary cancer.
Conclusions: Solitary and metachronous metastases from gastric cancer should be treated by a surgical approach and confer a better prognosis. A new prognostic factor, the presence of a pseudocapsule, may be helpful in defining indications for postoperative adjuvant treatment.
Figures
Similar articles
-
Hepatic resection for synchronous hepatic metastasis from gastric cancer.Eur J Surg Oncol. 2013 Jul;39(7):694-700. doi: 10.1016/j.ejso.2013.03.006. Epub 2013 Apr 8. Eur J Surg Oncol. 2013. PMID: 23579173
-
Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.Asian Pac J Cancer Prev. 2015;16(4):1665-9. doi: 10.7314/apjcp.2015.16.4.1665. Asian Pac J Cancer Prev. 2015. PMID: 25743789 Clinical Trial.
-
Outcome of hepatic resection for metastatic gastric cancer.Am Surg. 2005 Feb;71(2):95-9. Am Surg. 2005. PMID: 16022005
-
Liver metastases from gastric carcinoma: A Case report and review of the literature.Curr Probl Cancer. 2017 May-Jun;41(3):222-230. doi: 10.1016/j.currproblcancer.2017.03.003. Epub 2017 Mar 24. Curr Probl Cancer. 2017. PMID: 28625333 Review.
-
Resection of liver metastases from colorectal cancer. Indications and results.Dis Colon Rectum. 1994 Nov;37(11):1078-82. doi: 10.1007/BF02049807. Dis Colon Rectum. 1994. PMID: 7956573 Review.
Cited by
-
FOXP3+ Tregs exhibit different infiltrating status and predict a distinct prognosis in primary lesions and hepatic metastases in stage III&IV advanced gastric cancer.Am J Transl Res. 2020 Jul 15;12(7):3629-3644. eCollection 2020. Am J Transl Res. 2020. PMID: 32774723 Free PMC article.
-
Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.Gastric Cancer. 2016 Jul;19(3):951-60. doi: 10.1007/s10120-015-0522-z. Epub 2015 Aug 1. Gastric Cancer. 2016. PMID: 26231353
-
Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.World J Surg. 2015 Nov;39(11):2757-63. doi: 10.1007/s00268-015-3151-0. World J Surg. 2015. PMID: 26148522
-
Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.BMC Surg. 2012 Oct 12;12:20. doi: 10.1186/1471-2482-12-20. BMC Surg. 2012. PMID: 23062030 Free PMC article.
-
Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study.Med Oncol. 2010 Dec;27(4):1314-8. doi: 10.1007/s12032-009-9381-y. Epub 2009 Dec 5. Med Oncol. 2010. PMID: 19967569
References
-
- Scheele J, Stang R, Altendorf-Hoffmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77: 1241–1249. - PubMed
-
- Scheele J, Stang R, Altendorf-Hoffmann A, et al. Resection of colorectal metastases. World J Surg 1995; 19: 59–71. - PubMed
-
- Ochiai T, Sasako M, Mizuno S, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 1994; 81: 1175–1178. - PubMed
-
- Miyazaki M, Itoh H, Nakagawa K, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997; 92: 490–493. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical